Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Ascorbate and aldarate metabolism	9/26	5.4865874238937835E-14	1.7227406360573748E-11	0	0	84.74857685009488	2587.703285744668	UGT1A10;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Glucuronidation	9/27	8.18404102640083E-14	1.7227406360573748E-11	0	0	80.03629032258064	2411.813993593846	UGT1A10;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Pentose and glucuronate interconversions	9/29	1.729370182717544E-13	2.4268828230802868E-11	0	0	72.02540322580646	2116.5276178066706	UGT1A10;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Steroid hormone biosynthesis	10/56	3.2957565865534187E-12	3.4687838073474733E-10	0	0	35.031813361611874	926.1845814359634	UGT1A10;STS;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Porphyrin and chlorophyll metabolism	9/43	9.004794687911062E-12	7.582037127221115E-10	0	0	42.33799810246679	1076.7934803189905	UGT1A10;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Retinol metabolism	10/65	1.5754305825828816E-11	1.1054271254456554E-9	0	0	29.286031042128602	728.458024321416	UGT1A10;UGT1A1;ALDH1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Drug metabolism: other enzymes	9/52	5.586514449157788E-11	3.3598894044220413E-9	0	0	33.46136534133533	789.9586053965025	UGT1A10;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Starch and sucrose metabolism	9/53	6.691691711878189E-11	3.521502763375897E-9	0	0	32.699230205278596	766.0634819861034	UGT1A10;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Drug metabolism: cytochrome P450	10/83	1.935158180419179E-10	9.052239932849715E-9	0	0	22.044771132642833	493.04589692965993	UGT1A10;ALDH3A1;UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Estrogen metabolism	6/17	8.995061805175988E-10	3.786921019979091E-8	0	0	85.27988546886185	1776.3096747421948	NQO1;STS;UGT1A1;UGT1A3;UGT1A9;UGT1A6
Irinotecan pathway	5/13	1.4867264068051009E-8	5.690107429681341E-7	0	0	96.9677734375	1747.7572411775332	UGT1A10;UGT1A1;UGT1A9;ABCG2;UGT1A6
Phase II of biological oxidations: conjugation	8/71	2.3145149634861356E-8	8.120089996897193E-7	0	0	20.118349206349205	353.7103662227199	UGT1A1;UGT1A5;UGT1A4;UGT1A3;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Biological oxidations	10/139	3.0961864334966034E-8	1.0026880680785154E-6	0	0	12.43965462910443	215.0879674431269	UGT1A1;ALDH1A1;UGT1A5;UGT1A4;UGT1A3;CYP4F11;UGT1A9;UGT1A8;UGT1A7;UGT1A6
Metapathway biotransformation	9/174	2.506970732045967E-6	7.538819129938229E-5	0	0	8.666568914956011	111.76784626707091	UGT1A10;UGT1A1;UGT1A5;UGT1A4;UGT1A3;CYP4F11;UGT1A9;UGT1A7;UGT1A6
Tamoxifen metabolism	3/19	2.5768666911502486E-4	0.007232405846495031	0	0	28.63125	236.6019552089904	UGT1A10;UGT1A4;UGT1A8
BDNF signaling pathway	8/261	3.6358456111713563E-4	0.009566818764394632	0	0	4.9616442687747035	39.29373512672699	NQO1;BTG1;IGFBP5;ITGB5;GDF15;MYC;TXNIP;TGFBI
Nicotine metabolism	2/6	6.46948912530899E-4	0.0156306677746941	0	0	75.81297709923665	556.7131306118104	UGT1A4;UGT1A9
Interleukin-9 regulation of target genes	3/26	6.682945841911968E-4	0.0156306677746941	0	0	19.910367892976588	145.5603489980788	SOCS2;MYC;LCN2
Arylamine metabolism	2/7	9.0178315414844E-4	0.01998161620507859	0	0	60.64732824427481	425.20669500729895	UGT1A4;UGT1A9
Metabolism	22/1615	9.65874811037924E-4	0.020331664772348303	0	0	2.2736182510193808	15.784540885130177	UGT1A10;NQO1;UGT1A1;NFYA;CYP4F11;ALDH3A1;FLAD1;HYAL1;ALDH1A1;ME1;UGT1A5;ST3GAL5;UGT1A4;UPRT;UGT1A3;UGT1A9;LPIN1;UGT1A8;UGT1A7;ABCG2;LGMN;UGT1A6
Viral myocarditis	4/71	0.0012867100300256546	0.02579547250670479	0	0	9.163484901076016	60.98910115304818	HLA-DMB;MYH14;HLA-DRA;ICAM1
E2F-enabled inhibition of pre-replication complex formation	2/10	0.0019072718827723631	0.035957967144418304	0	0	37.89885496183206	237.32571441911304	CCNB1;ORC3
Cell adhesion molecules (CAMs)	5/133	0.0019644495114527812	0.035957967144418304	0	0	6.02386474609375	37.54399737997415	CDH3;HLA-DMB;CDH1;HLA-DRA;ICAM1
Antigen processing and presentation	4/81	0.0020935806759733865	0.03672489435769982	0	0	7.969394946139132	49.162236607278665	HLA-DMB;NFYA;HLA-DRA;LGMN
B lymphocyte cell surface molecules	2/11	0.0023209742239260786	0.03908520593091516	0	0	33.68617472434266	204.33252935417062	HLA-DRA;ICAM1
EGFR1 pathway	5/152	0.0034993613670008597	0.056662735981052384	0	0	5.240221088435374	29.634366212771596	BTG1;ITGB5;MYC;LCN2;TXNIP
TGF-beta regulation of extracellular matrix	10/565	0.004534531302803975	0.0707050992029805	0	0	2.8289753167801948	15.265245726692257	MYC;CEACAM5;COL7A1;NPR3;LCN2;ME1;TRIB3;TGFBI;GTPBP2;F3
Oncostatin M	7/311	0.004828947341341139	0.07260667252516498	0	0	3.575109649122807	19.066512999810573	CCNB1;CDH3;MYC;LCN2;F3;ICAM1;ABCG2
Fatty acid, triacylglycerol, and ketone body metabolism	5/173	0.006035660310469209	0.08762113761060474	0	0	4.5803106398809526	23.40570806902802	NFYA;ME1;TRIB3;UGT1A9;LPIN1
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	4/112	0.006675739788944588	0.09368288170485571	0	0	5.67298306057996	28.417533644890142	NFYA;ME1;TRIB3;UGT1A9
Beta-1 integrin cell surface interactions	3/66	0.009697294459777631	0.13169551508278654	0	0	7.254212454212454	33.629864118545	COL7A1;F13A1;TGFBI
G1 to S cell cycle control	3/67	0.010103293762419658	0.13292145856183363	0	0	7.140504807692308	32.8098612212361	CCNB1;MYC;ORC3
Interleukin-2 signaling pathway	12/847	0.010935528905340823	0.1363027337930828	0	0	2.2604444004552877	10.207575259009412	SOCS2;ALDH3A1;BTG1;WARS;MYC;HMHA1;TARS;TNFRSF14;ZSWIM6;SUOX;ICAM1;FKTN
Cytosolic tRNA aminoacylation	2/24	0.011007821731507874	0.1363027337930828	0	0	13.771686328938237	62.09858828771937	WARS;TARS
Costimulation by the CD28 family	3/72	0.012280543881752018	0.14771739926336	0	0	6.621404682274248	29.132452860336144	HLA-DRA;TRIB3;TNFRSF14
Diabetes pathways	4/137	0.013303195566613859	0.1507478509071918	0	0	4.600804336422452	19.874329153528432	IGFBP5;NFYA;WFS1;MYC
TWEAK regulation of gene expression	2/27	0.013818646080876924	0.1507478509071918	0	0	12.117251908396947	51.88287897057053	F3;ICAM1
Oxidative stress	2/27	0.013818646080876924	0.1507478509071918	0	0	12.117251908396947	51.88287897057053	NQO1;UGT1A6
p53 signaling pathway	4/139	0.013964765285939384	0.1507478509071918	0	0	4.532184898076371	19.357949204011682	CCNB1;NFYA;GDF15;CX3CL1
p73 transcription factor network	3/79	0.01574730488464939	0.15514831274460428	0	0	6.009412955465587	24.945590268819537	CCNB1;GDF15;MYC
Adherens junction actin cytoskeletal organization	2/29	0.015846502251824192	0.15514831274460428	0	0	11.218546791065876	46.49870544847218	CDH3;CDH1
Thyroid cancer	2/29	0.015846502251824192	0.15514831274460428	0	0	11.218546791065876	46.49870544847218	CDH1;MYC
Integrin beta-2 pathway	2/29	0.015846502251824192	0.15514831274460428	0	0	11.218546791065876	46.49870544847218	TGFBI;ICAM1
Asthma	2/30	0.01690529038501182	0.16175289209295401	0	0	10.817339149400219	44.136135547977105	HLA-DMB;HLA-DRA
SMAD2/3 nuclear pathway	3/82	0.017384553990319344	0.16264216066498766	0	0	5.78033106134372	23.42290243302603	ITGB5;MYC;RUNX1
Fibrin clot formation (clotting cascade)	2/32	0.019110411413020896	0.16764046027944124	0	0	10.095165394402036	39.95183906409564	F13A1;F3
C-Myb transcription factor network	3/85	0.019113401647062184	0.16764046027944124	0	0	5.568011257035647	22.03465583629091	CCNB1;MYC;LYZ
Integrin cell surface interactions	3/85	0.019113401647062184	0.16764046027944124	0	0	5.568011257035647	22.03465583629091	ITGB5;CDH1;ICAM1
E2F-mediated regulation of DNA replication	2/33	0.020255887331898044	0.17403527687202197	0	0	9.769022408273825	38.092444766546755	CCNB1;ORC3
Allograft rejection	2/37	0.02511409677524347	0.21146069484755	0	0	8.65081788440567	31.872432958520882	HLA-DMB;HLA-DRA
TSH regulation of gene expression	3/97	0.026948698601798767	0.2182993264602899	0	0	4.854255319148936	17.542406278538294	MYC;FAM110B;ICAM1
FOXM1 transcription factor network	2/41	0.030394798689099053	0.2182993264602899	0	0	7.761988647484831	27.116381447998105	CCNB1;MYC
Graft-versus-host disease	2/41	0.030394798689099053	0.2182993264602899	0	0	7.761988647484831	27.116381447998105	HLA-DMB;HLA-DRA
MHC class II antigen presentation	3/103	0.03141753247949506	0.2182993264602899	0	0	4.561615384615385	15.784964532437124	HLA-DMB;HLA-DRA;LGMN
Bladder cancer	2/42	0.03177800408907005	0.2182993264602899	0	0	7.567557251908397	26.100360601897908	CDH1;MYC
Abacavir transmembrane transport	1/5	0.032813749721153695	0.2182993264602899	0	0	37.61931818181818	128.54173618163773	ABCG2
Chk1/Chk2(Cds1)-mediated inactivation of cyclin B-Cdk1 complex	1/5	0.032813749721153695	0.2182993264602899	0	0	37.61931818181818	128.54173618163773	CCNB1
Sulfide oxidation to sulfate	1/5	0.032813749721153695	0.2182993264602899	0	0	37.61931818181818	128.54173618163773	SUOX
Cytochrome P450 metabolism of miscellaneous substrates	1/5	0.032813749721153695	0.2182993264602899	0	0	37.61931818181818	128.54173618163773	CYP4F11
Extrinsic pathway	1/5	0.032813749721153695	0.2182993264602899	0	0	37.61931818181818	128.54173618163773	F3
Folate-alcohol and cancer pathway	1/5	0.032813749721153695	0.2182993264602899	0	0	37.61931818181818	128.54173618163773	ALDH1A1
Heme degradation	1/5	0.032813749721153695	0.2182993264602899	0	0	37.61931818181818	128.54173618163773	UGT1A1
Type 1 diabetes mellitus	2/43	0.033185645827692525	0.2182993264602899	0	0	7.382610314652765	25.14249712779407	HLA-DMB;HLA-DRA
G2/M checkpoints	2/43	0.033185645827692525	0.2182993264602899	0	0	7.382610314652765	25.14249712779407	CCNB1;ORC3
Syndecan 1 pathway	2/46	0.037551400127929575	0.23533785944254562	0	0	6.878209576682859	22.574590698130514	COL16A1;COL7A1
Transfer RNA aminoacylation	2/46	0.037551400127929575	0.23533785944254562	0	0	6.878209576682859	22.574590698130514	WARS;TARS
Phosphorylation of Emi1	1/6	0.03924712768834303	0.23533785944254562	0	0	30.093939393939394	97.44047472504964	CCNB1
Assembly of the ORC complex at the origin of replication	1/6	0.03924712768834303	0.23533785944254562	0	0	30.093939393939394	97.44047472504964	ORC3
Interleukin-1-beta (IL-1b) processing pathway	1/6	0.03924712768834303	0.23533785944254562	0	0	30.093939393939394	97.44047472504964	STS
Generic transcription pathway	6/377	0.04035282628832836	0.23533785944254562	0	0	2.4826707982256937	7.9696062420875196	MYC;ZNF549;ZNF514;ZNF546;ZNF23;ZNF223
Intestinal immune network for IgA production	2/48	0.04057720615687149	0.23533785944254562	0	0	6.578493196150016	21.081102442927243	HLA-DMB;HLA-DRA
Interleukin-5 signaling pathway	2/49	0.04212360389231727	0.23533785944254562	0	0	6.43820042228358	20.3907273645284	MYC;HLA-DRA
Lipid and lipoprotein metabolism	7/489	0.045117564860276696	0.23533785944254562	0	0	2.234324573536192	6.923018145470467	STS;NFYA;ME1;TRIB3;UGT1A9;LPIN1;LGMN
Amyloids	2/51	0.04528159945206039	0.23533785944254562	0	0	6.174793581554759	19.11008783905185	TGFBI;LYZ
SLC26 family multifunctional anion exchangers	1/7	0.04563803451072045	0.23533785944254562	0	0	25.0770202020202	77.41310792741105	SLC26A9
Telomerase RNA component gene hTERC transcriptional regulation	1/7	0.04563803451072045	0.23533785944254562	0	0	25.0770202020202	77.41310792741105	NFYA
Vitamin D (calciferol) metabolism	1/7	0.04563803451072045	0.23533785944254562	0	0	25.0770202020202	77.41310792741105	LGMN
Negative regulation of the PI3K/Akt network	1/7	0.04563803451072045	0.23533785944254562	0	0	25.0770202020202	77.41310792741105	TRIB3
Interleukin-1 regulation of extracellular matrix	3/120	0.046041192424495406	0.23533785944254562	0	0	3.8954635108481264	11.991088997109701	ALDH1A1;ICAM1;RUNX1
Autoimmune thyroid disease	2/52	0.04689249263679048	0.23533785944254562	0	0	6.050992366412213	18.51541755241091	HLA-DMB;HLA-DRA
Endometrial cancer	2/52	0.04689249263679048	0.23533785944254562	0	0	6.050992366412213	18.51541755241091	CDH1;MYC
Interleukin-2 receptor beta chain in T cell activation	2/52	0.04689249263679048	0.23533785944254562	0	0	6.050992366412213	18.51541755241091	CCNB1;MYC
Lysosome	3/121	0.04698992159206642	0.23533785944254562	0	0	3.8622555410691004	11.810090482490372	MANBA;HYAL1;LGMN
Adaptive immune system	8/606	0.04957401829374703	0.23533785944254562	0	0	2.0622341137123748	6.195546040795982	HLA-DMB;ITGB5;CDH1;HLA-DRA;TRIB3;TNFRSF14;ICAM1;LGMN
TAp63 pathway	2/55	0.05184860270843882	0.23533785944254562	0	0	5.7076191847904365	16.89128399579087	NQO1;GDF15
Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs)	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	MYC
Bystander B cell activation	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	HLA-DRA
Shuttle for transfer of acetyl groups from mitochondria to the cytosol	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	ME1
Codeine and morphine metabolism	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	UGT1A1
Cross-presentation of particulate exogenous antigens (phagosomes)	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	ITGB5
Degradation of cysteine and homocysteine	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	SUOX
Eosinophils in the chemokine network of allergy	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	HLA-DRA
Organic cation transport	1/8	0.05198674804787824	0.23533785944254562	0	0	21.493506493506494	63.55127863735061	SLC22A15
Acute myeloid leukemia	2/57	0.05525214734628765	0.24485425297670635	0	0	5.499514226231783	15.925757676357827	MYC;RUNX1
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	2/57	0.05525214734628765	0.24485425297670635	0	0	5.499514226231783	15.925757676357827	MYC;ME1
Tryptophan metabolism	2/58	0.05698276334815424	0.24789476990756534	0	0	5.40103598691385	15.474002962305127	WARS;ALDH1A1
Calcium-activated potassium channels	1/9	0.058293544467574746	0.24789476990756534	0	0	18.80587121212121	53.45124925484205	KCNMB2
G2/M DNA damage checkpoint	1/9	0.058293544467574746	0.24789476990756534	0	0	18.80587121212121	53.45124925484205	CCNB1
PI3K/AKT signalling	1/9	0.058293544467574746	0.24789476990756534	0	0	18.80587121212121	53.45124925484205	TRIB3
RAGE pathway	2/60	0.06050005462609634	0.24832854140713542	0	0	5.214266912345354	14.626597530295765	F3;ICAM1
Selenium pathway	2/60	0.06050005462609634	0.24832854140713542	0	0	5.214266912345354	14.626597530295765	FLAD1;ICAM1
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	3/135	0.06126662004909961	0.24832854140713542	0	0	3.450174825174825	9.634682612074325	OPTN;CX3CL1;ICAM1
Mitotic G1-G1/S phases	3/135	0.06126662004909961	0.24832854140713542	0	0	3.450174825174825	9.634682612074325	CCNB1;MYC;ORC3
Leptin signaling pathway	2/61	0.06228608893497304	0.24832854140713542	0	0	5.125630741363695	14.228838943544543	SOCS2;CFL2
Licensing factor removal from origins	2/61	0.06228608893497304	0.24832854140713542	0	0	5.125630741363695	14.228838943544543	NQO1;ORC3
Abacavir transport and metabolism	1/10	0.06455869825192352	0.24832854140713542	0	0	16.715488215488215	45.803453495550436	ABCG2
Activation of Src by protein tyrosine phosphatase alpha	1/10	0.06455869825192352	0.24832854140713542	0	0	16.715488215488215	45.803453495550436	CCNB1
Ethanol oxidation	1/10	0.06455869825192352	0.24832854140713542	0	0	16.715488215488215	45.803453495550436	ALDH1A1
Ganglio sphingolipid metabolism	1/10	0.06455869825192352	0.24832854140713542	0	0	16.715488215488215	45.803453495550436	ST3GAL5
Folate metabolism	2/63	0.06591135778480284	0.24832854140713542	0	0	4.957076711300212	13.480495016176326	FLAD1;ICAM1
Collagen biosynthesis and modifying enzymes	2/64	0.06774997144464087	0.24832854140713542	0	0	4.876877616350653	13.128219212543067	COL16A1;COL7A1
ERK1/ERK2 MAPK pathway	2/65	0.06960549619163363	0.24832854140713542	0	0	4.799224524415364	12.789509809152563	MYC;MKNK2
Apoptotic cleavage of cell adhesion  proteins	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	CDH1
Recruitment of NuMA to mitotic centrosomes	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	CCNB1
BTG family proteins and cell cycle regulation	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	BTG1
SUMOylation as a mechanism to modulate CtBP-dependent gene responses	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	CDH1
CDC6 association with the ORC-origin complex	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	ORC3
Sonic Hedgehog (SHH) receptor PTCH1 regulation of cell cycle	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	CCNB1
Telomerase protein component gene hTERT transcriptional regulation	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	MYC
Monocyte and its surface molecules	1/11	0.0707824821112975	0.24832854140713542	0	0	15.043181818181818	39.836507711922266	ICAM1
Phosphatidylethanolamine biosynthesis	1/12	0.07696516706764417	0.25376149213970134	0	0	13.674931129476583	35.06802532248599	LPIN1
Activation of chaperones by ATF6 alpha	1/12	0.07696516706764417	0.25376149213970134	0	0	13.674931129476583	35.06802532248599	NFYA
Toll-like receptor endosomal trafficking and processing	1/12	0.07696516706764417	0.25376149213970134	0	0	13.674931129476583	35.06802532248599	LGMN
Phase I of biological oxidations: functionalization of compounds	2/69	0.07719070879200446	0.25376149213970134	0	0	4.51179218411758	11.556848216079398	ALDH1A1;CYP4F11
Complement and coagulation cascades	2/70	0.07912631894369963	0.25376149213970134	0	0	4.4452177817691965	11.276227196947195	F13A1;F3
MicroRNA regulation of DNA damage response	2/70	0.07912631894369963	0.25376149213970134	0	0	4.4452177817691965	11.276227196947195	CCNB1;MYC
Leishmaniasis	2/72	0.08304269155518629	0.25376149213970134	0	0	4.317775354416576	10.744354123420981	HLA-DMB;HLA-DRA
Arylsulfatase activation	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	STS
CTL mediated immune response against target cells	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	ICAM1
Chondroitin sulfate/dermatan sulfate degradation	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	HYAL1
Sulfur metabolism	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	SUOX
T helper cell surface molecules	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	ICAM1
Ghrelin-mediated regulation of food intake and energy homeostasis	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	IGFBP5
Keap1-Nrf2 pathway	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	NQO1
Lck and Fyn tyrosine kinases in initiation of T cell receptor activation	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	HLA-DRA
Organic cation/anion/zwitterion transport	1/13	0.08310702236346885	0.25376149213970134	0	0	12.534722222222221	31.1817018518508	SLC22A15
Phagosome	3/154	0.08345674148441691	0.25376149213970134	0	0	3.013143148242486	7.482920589473447	HLA-DMB;ITGB5;HLA-DRA
Chronic myeloid leukemia	2/73	0.08502289030340904	0.25376149213970134	0	0	4.2567465863885605	10.492176955148778	MYC;RUNX1
Myc repressed pathway	2/73	0.08502289030340904	0.25376149213970134	0	0	4.2567465863885605	10.492176955148778	NFYA;MYC
RANKL regulation of apoptosis and immune response	2/74	0.08701739323137853	0.25376149213970134	0	0	4.197413061916879	10.248602093782685	TXNIP;ICAM1
Integrins in angiogenesis	2/74	0.08701739323137853	0.25376149213970134	0	0	4.197413061916879	10.248602093782685	COL16A1;COL7A1
Prolactin activation of MAPK signaling	2/75	0.08902592606726308	0.25376149213970134	0	0	4.1397051134581195	10.013233181112826	SOCS2;MYC
Porphyrin metabolism	1/14	0.08920831552654583	0.25376149213970134	0	0	11.56993006993007	27.961987399777197	UGT1A1
Adhesion and diapedesis of lymphocytes	1/14	0.08920831552654583	0.25376149213970134	0	0	11.56993006993007	27.961987399777197	ICAM1
Coagulation common pathway	1/14	0.08920831552654583	0.25376149213970134	0	0	11.56993006993007	27.961987399777197	F13A1
DCC-mediated attractive signaling	1/14	0.08920831552654583	0.25376149213970134	0	0	11.56993006993007	27.961987399777197	ABLIM3
Hyaluronan metabolism	1/14	0.08920831552654583	0.25376149213970134	0	0	11.56993006993007	27.961987399777197	HYAL1
Interleukin-6 regulation of target genes	1/14	0.08920831552654583	0.25376149213970134	0	0	11.56993006993007	27.961987399777197	ICAM1
AKAP95 role in mitosis and chromosome dynamics	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	CCNB1
Adhesion and diapedesis of granulocytes	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	ICAM1
Association of licensing factors with the pre-replicative complex	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	ORC3
Cyclin A/B1-associated events during G2/M transition	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	CCNB1
Extrinsic prothrombin activation pathway	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	F3
Fatty acid omega oxidation	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	ALDH1A1
Fibrinolysis pathway	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	F13A1
Glycosphingolipid biosynthesis: ganglio series	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	ST3GAL5
PRC2 complex long-term gene silencing through modification of histone tails	1/15	0.09526931236514509	0.2554673917562171	0	0	10.742965367965368	25.25722220437665	EZH1
Unfolded protein response	2/79	0.097194973114033	0.2589815422848601	0	0	3.92386239714484	9.146665628179496	NFYA;WFS1
Nuclear beta-catenin signaling and target gene transcription regulation	2/80	0.0992696434680371	0.26178647612255135	0	0	3.873360735956156	8.94713584585087	CDH1;MYC
Riboflavin metabolism	1/16	0.10129027694516599	0.26178647612255135	0	0	10.026262626262627	22.957783789683365	FLAD1
Control of cell cycle and breast tumor growth by estrogen-responsive protein Efp	1/16	0.10129027694516599	0.26178647612255135	0	0	10.026262626262627	22.957783789683365	CCNB1
Other glycan degradation	1/16	0.10129027694516599	0.26178647612255135	0	0	10.026262626262627	22.957783789683365	MANBA
MAP kinase signaling pathway	2/81	0.10135675916383817	0.26178647612255135	0	0	3.8241375978355396	8.75386671022096	MYC;MKNK2
Phenylalanine metabolism	1/17	0.10727147167528207	0.26513213842148453	0	0	9.399147727272727	20.98258726036805	ALDH3A1
Cadmium-induced DNA biosynthesis and proliferation in macrophages	1/17	0.10727147167528207	0.26513213842148453	0	0	9.399147727272727	20.98258726036805	MYC
Cell to cell adhesion signaling	1/17	0.10727147167528207	0.26513213842148453	0	0	9.399147727272727	20.98258726036805	CDH1
Cells and molecules involved in local acute inflammatory response	1/17	0.10727147167528207	0.26513213842148453	0	0	9.399147727272727	20.98258726036805	ICAM1
Inflammasomes	1/17	0.10727147167528207	0.26513213842148453	0	0	9.399147727272727	20.98258726036805	TXNIP
Insulin-like growth factor (IGF) activity regulation by insulin-like growth factor binding proteins (IGFBPs)	1/17	0.10727147167528207	0.26513213842148453	0	0	9.399147727272727	20.98258726036805	IGFBP5
Integrin beta-5 pathway	1/17	0.10727147167528207	0.26513213842148453	0	0	9.399147727272727	20.98258726036805	ITGB5
Cell junction organization	2/84	0.10769025099780014	0.26513213842148453	0	0	3.683671569540123	8.209048164390554	CDH3;CDH1
Myc active pathway	2/85	0.10982463461697008	0.26881494868456046	0	0	3.639106042490573	8.038313678244936	CCNB1;MYC
Phosphatidylcholine biosynthesis	1/18	0.11321315720990713	0.27235850963069086	0	0	8.845811051693405	19.270448026035922	LPIN1
CDK regulation of DNA replication	1/18	0.11321315720990713	0.27235850963069086	0	0	8.845811051693405	19.270448026035922	ORC3
Downregulation of MTA-3 in ER-negative breast tumors	1/18	0.11321315720990713	0.27235850963069086	0	0	8.845811051693405	19.270448026035922	CDH1
Cell cycle progression regulation by PLK3	1/19	0.11911559255229133	0.2785981359139703	0	0	8.353956228956228	17.77438595644681	CCNB1
TP53 network	1/19	0.11911559255229133	0.2785981359139703	0	0	8.353956228956228	17.77438595644681	MYC
Telomeres, telomerase, cellular aging, and immortality	1/19	0.11911559255229133	0.2785981359139703	0	0	8.353956228956228	17.77438595644681	MYC
Glycosaminoglycan degradation	1/19	0.11911559255229133	0.2785981359139703	0	0	8.353956228956228	17.77438595644681	HYAL1
Inhibition of T cell receptor signaling by activated Csk	1/19	0.11911559255229133	0.2785981359139703	0	0	8.353956228956228	17.77438595644681	HLA-DRA
Thymic stromal lymphopoietin (TSLP) pathway	2/90	0.1206598187017143	0.28065073852719186	0	0	3.43147120055517	7.256807037912687	MYC;ICAM1
Neural crest differentiation	2/91	0.12285786250469374	0.2841931874421762	0	0	3.3927438030705894	7.113658150782295	CDH1;MYC
ID regulation of gene expression	1/20	0.12497903497150159	0.2875200749890829	0	0	7.913875598086125	16.457769102687624	ICAM1
Extracellular matrix organization	2/93	0.12728312241557282	0.2898335505199354	0	0	3.317842462880631	6.839205905947969	COL16A1;COL7A1
Immune system	10/998	0.1284237590053375	0.2898335505199354	0	0	1.5535202922879432	3.1884759099107356	SOCS2;HLA-DMB;ITGB5;CDH1;TXNIP;HLA-DRA;TRIB3;TNFRSF14;ICAM1;LGMN
APC/C activator regulation between G1/S and early anaphase	1/21	0.1308037401396383	0.2898335505199354	0	0	7.51780303030303	15.291641727999936	CCNB1
CD28-dependent PI3K/Akt signaling	1/21	0.1308037401396383	0.2898335505199354	0	0	7.51780303030303	15.291641727999936	TRIB3
T cell activation co-stimulatory signal	1/21	0.1308037401396383	0.2898335505199354	0	0	7.51780303030303	15.291641727999936	HLA-DRA
E-cadherin keratinocyte pathway	1/21	0.1308037401396383	0.2898335505199354	0	0	7.51780303030303	15.291641727999936	CDH1
Oxidative stress-induced gene expression via Nrf2	1/21	0.1308037401396383	0.2898335505199354	0	0	7.51780303030303	15.291641727999936	UGT1A6
Interferon-gamma signaling pathway	2/97	0.13624412304839678	0.2995019479925126	0	0	3.1775010044194456	6.333734930935417	HLA-DRA;ICAM1
Smooth muscle contraction	1/22	0.13658996202983947	0.2995019479925126	0	0	7.159451659451659	14.252834602798108	ITGB5
Wnt signaling pathway and pluripotency	2/98	0.1385061254694135	0.30212994208613	0	0	3.1442430025445294	6.2156676233819015	NFYA;MYC
Progesterone-initiated oocyte maturation	1/23	0.1423379529533211	0.3026478696633747	0	0	6.833677685950414	13.322603840135233	CCNB1
Cyclins and cell cycle regulation	1/23	0.1423379529533211	0.3026478696633747	0	0	6.833677685950414	13.322603840135233	CCNB1
Th1/Th2 differentiation pathway	1/23	0.1423379529533211	0.3026478696633747	0	0	6.833677685950414	13.322603840135233	HLA-DRA
Hypoxia and p53 in the cardiovascular system	1/23	0.1423379529533211	0.3026478696633747	0	0	6.833677685950414	13.322603840135233	NQO1
Interleukin-11 pathway	1/23	0.1423379529533211	0.3026478696633747	0	0	6.833677685950414	13.322603840135233	ICAM1
SREBP signaling	1/24	0.1480479635854841	0.30703543186940296	0	0	6.536231884057971	12.485634198946752	NFYA
Sulfur amino acid metabolism	1/24	0.1480479635854841	0.30703543186940296	0	0	6.536231884057971	12.485634198946752	SUOX
Dorso-ventral axis formation	1/24	0.1480479635854841	0.30703543186940296	0	0	6.536231884057971	12.485634198946752	SPIRE1
Tumor suppressor Arf inhibits ribosomal biogenesis	1/24	0.1480479635854841	0.30703543186940296	0	0	6.536231884057971	12.485634198946752	MYC
Inhibition of cellular proliferation by Gleevec	1/24	0.1480479635854841	0.30703543186940296	0	0	6.536231884057971	12.485634198946752	MYC
APC/C- and Cdc20-mediated degradation of Nek2A	1/25	0.15372024298700074	0.31415641892003554	0	0	6.263573232323233	11.729298347565283	CCNB1
Alpha-9 beta-1 integrin pathway	1/25	0.15372024298700074	0.31415641892003554	0	0	6.263573232323233	11.729298347565283	F13A1
C-Myc pathway	1/25	0.15372024298700074	0.31415641892003554	0	0	6.263573232323233	11.729298347565283	MYC
Fibroblast growth factor 1	1/26	0.15935503861639075	0.32099747013158136	0	0	6.012727272727273	11.04309888437679	F3
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP	1/26	0.15935503861639075	0.32099747013158136	0	0	6.012727272727273	11.04309888437679	MYC
Integrin family cell surface interactions	1/26	0.15935503861639075	0.32099747013158136	0	0	6.012727272727273	11.04309888437679	ITGB5
Disease	7/674	0.16265333304080018	0.326081205762747	0	0	1.5992003998000999	2.9043624334524205	IGFBP5;NFYA;WFS1;MYC;TRIB3;TGFBI;LYZ
CTCF pathway	1/27	0.16495259629777692	0.3275709577422834	0	0	5.781177156177156	10.418242827789005	MYC
Cell cycle: G2/M checkpoint	1/27	0.16495259629777692	0.3275709577422834	0	0	5.781177156177156	10.418242827789005	CCNB1
Leptin influence on immune response	2/110	0.16623801544453623	0.3285737300570411	0	0	2.7931863160870796	5.011911101460653	LYZ;CX3CL1
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation	1/28	0.17051316022960905	0.3301410385840692	0	0	5.566778900112234	9.847313449757165	STS
RNA polymerase III transcription initiation From type 3 promoter	1/28	0.17051316022960905	0.3301410385840692	0	0	5.566778900112234	9.847313449757165	BRF2
Nitric oxide stimulation of guanylate cyclase	1/28	0.17051316022960905	0.3301410385840692	0	0	5.566778900112234	9.847313449757165	KCNMB2
PERK-regulated gene expression	1/28	0.17051316022960905	0.3301410385840692	0	0	5.566778900112234	9.847313449757165	NFYA
S phase	2/112	0.17095189171336597	0.3301410385840692	0	0	2.742123525329632	4.843613223988164	MYC;ORC3
Sema4D in semaphorin signaling	1/29	0.17603697306522068	0.33687075300208136	0	0	5.367694805194805	9.324014550089352	MYH14
Histidine metabolism	1/29	0.17603697306522068	0.33687075300208136	0	0	5.367694805194805	9.324014550089352	ALDH3A1
Activation of the pre-replicative complex	1/30	0.18152427589102918	0.34269829663732415	0	0	5.182340647857889	8.842969274321403	ORC3
Interleukin-2/STAT5 pathway	1/30	0.18152427589102918	0.34269829663732415	0	0	5.182340647857889	8.842969274321403	MYC
Nectin adhesion pathway	1/30	0.18152427589102918	0.34269829663732415	0	0	5.182340647857889	8.842969274321403	CDH1
Cell cycle checkpoints	2/117	0.1828311031823104	0.34342063295210024	0	0	2.6222369731164954	4.455685360538681	CCNB1;ORC3
Prolactin regulation of apoptosis	2/118	0.18522176470658286	0.34342063295210024	0	0	2.5994998683864177	4.38328043086988	SOCS2;ABCG2
CD28 co-stimulation	1/31	0.18697530817141164	0.34342063295210024	0	0	5.009343434343434	8.399560435360442	TRIB3
CD40/CD40L signaling	1/31	0.18697530817141164	0.34342063295210024	0	0	5.009343434343434	8.399560435360442	MYC
Stathmin and breast cancer resistance to antimicrotubule agents	1/31	0.18697530817141164	0.34342063295210024	0	0	5.009343434343434	8.399560435360442	CCNB1
PD-1 signaling	1/31	0.18697530817141164	0.34342063295210024	0	0	5.009343434343434	8.399560435360442	HLA-DRA
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	2/119	0.1876169728716937	0.34342063295210024	0	0	2.577151432113264	4.312483494782131	CDH1;ICAM1
Actin cytoskeleton regulation	3/226	0.19073634049364036	0.3476190447957688	0	0	2.0328389099689548	3.3681360238432654	ITGB5;CFL2;MYH14
Gene expression	9/968	0.19577596837940392	0.3552658736540045	0	0	1.4310269433886105	2.333696260660942	WARS;BRF2;MYC;ZNF549;TARS;ZNF514;ZNF546;ZNF23;ZNF223
Fluoropyrimidine activity	1/33	0.19776951129891399	0.3573431942353768	0	0	4.695785984848484	7.6102396939897305	ABCG2
EGF receptor transactivation by GPCRs in cardiac hypertrophy	1/34	0.20311315338179647	0.36387505350526095	0	0	4.553259871441689	7.257860033982993	MYC
HIF-2-alpha transcription factor network	1/34	0.20311315338179647	0.36387505350526095	0	0	4.553259871441689	7.257860033982993	ABCG2
Cytokines and inflammatory response	1/35	0.2084214674304456	0.3671357229632536	0	0	4.419117647058823	6.930029199904228	HLA-DRA
Interleukin-2/PI3K pathway	1/35	0.2084214674304456	0.3671357229632536	0	0	4.419117647058823	6.930029199904228	MYC
Interleukin-7 signaling pathway	1/35	0.2084214674304456	0.3671357229632536	0	0	4.419117647058823	6.930029199904228	MYC
MEF2D role in T cell apoptosis	1/35	0.2084214674304456	0.3671357229632536	0	0	4.419117647058823	6.930029199904228	HLA-DRA
Cell-cell communication	2/129	0.2117838822110028	0.3687109117854313	0	0	2.373023982689187	3.6833815988151555	CDH3;CDH1
T cell receptor regulation of apoptosis	6/603	0.21348206496843586	0.3687109117854313	0	0	1.5249475725082104	2.354827784715945	NQO1;CCNB1;BTG1;IGFBP5;NFYA;MYC
Steroid hormone, vitamin A, and vitamin D metabolism	1/36	0.21369468521530935	0.3687109117854313	0	0	4.292640692640693	6.624433110738544	LGMN
Generation of second messenger molecules	1/36	0.21369468521530935	0.3687109117854313	0	0	4.292640692640693	6.624433110738544	HLA-DRA
Ion transport by P-type ATPases	1/36	0.21369468521530935	0.3687109117854313	0	0	4.292640692640693	6.624433110738544	ATP7B
PI3K/AKT activation	1/37	0.21893303705074071	0.37620738203412996	0	0	4.173190235690235	6.339031577010457	TRIB3
Adipogenesis	2/133	0.22153864207134322	0.3789621384732655	0	0	2.300099061826234	3.466613273188395	TRIB3;LPIN1
Striated muscle contraction	1/38	0.22413675173359407	0.3789621384732655	0	0	4.060196560196561	6.0720195488162965	MYOM1
Triglyceride biosynthesis	1/38	0.22413675173359407	0.3789621384732655	0	0	4.060196560196561	6.0720195488162965	LPIN1
Glycosphingolipid metabolism	1/38	0.22413675173359407	0.3789621384732655	0	0	4.060196560196561	6.0720195488162965	STS
E-cadherin nascent AJ-like junctions pathway	1/39	0.22930605652927846	0.38007027479852845	0	0	3.9531499202551834	5.821794701796659	CDH1
Vitamin A and carotenoid metabolism	1/39	0.22930605652927846	0.38007027479852845	0	0	3.9531499202551834	5.821794701796659	ALDH1A1
G13 signaling pathway	1/39	0.22930605652927846	0.38007027479852845	0	0	3.9531499202551834	5.821794701796659	CFL2
GAB1 signalosome	1/39	0.22930605652927846	0.38007027479852845	0	0	3.9531499202551834	5.821794701796659	TRIB3
Iron uptake and transport	1/39	0.22930605652927846	0.38007027479852845	0	0	3.9531499202551834	5.821794701796659	ABCG2
Systemic lupus erythematosus	2/139	0.23623642707418852	0.39002170901267985	0	0	2.198696160918259	3.1725474264406555	HLA-DMB;HLA-DRA
Alpha-M beta-2 integrin signaling	1/41	0.23954233834227537	0.3908811024887517	0	0	3.755113636363636	5.3661516386174855	ICAM1
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	1/41	0.23954233834227537	0.3908811024887517	0	0	3.755113636363636	5.3661516386174855	MYC
Tyrosine metabolism	1/41	0.23954233834227537	0.3908811024887517	0	0	3.755113636363636	5.3661516386174855	ALDH3A1
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1/42	0.24460976259810135	0.3960796540530795	0	0	3.6633407243163343	5.158317631448959	ITGB5
Netrin-1 signaling	1/42	0.24460976259810135	0.3960796540530795	0	0	3.6633407243163343	5.158317631448959	ABLIM3
Interleukin-5 regulation of apoptosis	2/144	0.2485265429238713	0.3996197174471031	0	0	2.120739705408021	2.952505750377688	QSOX1;ICAM1
Beta-3 integrin cell surface interactions	1/43	0.24964367146933045	0.3996197174471031	0	0	3.5759379509379507	4.962403087713681	TGFBI
Growth hormone receptor signaling	1/43	0.24964367146933045	0.3996197174471031	0	0	3.5759379509379507	4.962403087713681	SOCS2
PI3K events in ERBB2 signaling	1/44	0.254644285017576	0.4052163005355951	0	0	3.492600422832981	4.777485049050839	TRIB3
FSH regulation of apoptosis	3/263	0.2550648922611228	0.4052163005355951	0	0	1.7402662721893492	2.3776166699258647	IGFBP5;ITGB5;CX3CL1
RNA polymerase III transcription	1/45	0.2596118217355405	0.4078230483233677	0	0	3.413050964187328	4.602730483015938	BRF2
Wnt interactions in lipid metabolism and immune response	1/45	0.2596118217355405	0.4078230483233677	0	0	3.413050964187328	4.602730483015938	MYC
Interleukin-12/STAT4 pathway	1/45	0.2596118217355405	0.4078230483233677	0	0	3.413050964187328	4.602730483015938	HLA-DRA
Interleukin-4 regulation of apoptosis	3/267	0.262216993422205	0.4095228589883248	0	0	1.713548951048951	2.2937273221934524	MYC;F13A1;F3
Polo-like kinase 1 (PLK1) pathway	1/46	0.26454649880748893	0.4095228589883248	0	0	3.337037037037037	4.437385770595149	CCNB1
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	1/46	0.26454649880748893	0.4095228589883248	0	0	3.337037037037037	4.437385770595149	CDH1
Integrated breast cancer pathway	2/152	0.2682295001796522	0.4095228589883248	0	0	2.006819338422392	2.6407982933921867	CDH1;MYC
ABC transporters	1/47	0.2694485319234346	0.4095228589883248	0	0	3.264328063241107	4.280767625110474	ABCG2
Regulation of transcription by NOTCH1 intracellular domain	1/47	0.2694485319234346	0.4095228589883248	0	0	3.264328063241107	4.280767625110474	MYC
Delta Np63 pathway	1/47	0.2694485319234346	0.4095228589883248	0	0	3.264328063241107	4.280767625110474	RUNX1
LKB1 signaling events	1/47	0.2694485319234346	0.4095228589883248	0	0	3.264328063241107	4.280767625110474	MYC
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/47	0.2694485319234346	0.4095228589883248	0	0	3.264328063241107	4.280767625110474	TXNIP
Activation of chaperones by IRE1 alpha	1/48	0.2743181354387822	0.40953168446711813	0	0	3.1947130883301096	4.132255212667504	WFS1
Post-translational regulation of adherens junction stability and disassembly	1/48	0.2743181354387822	0.40953168446711813	0	0	3.1947130883301096	4.132255212667504	CDH1
Presenilin action in Notch and Wnt signaling	1/48	0.2743181354387822	0.40953168446711813	0	0	3.1947130883301096	4.132255212667504	MYC
Chondroitin sulfate/dermatan sulfate metabolism	1/48	0.2743181354387822	0.40953168446711813	0	0	3.1947130883301096	4.132255212667504	HYAL1
Diurnally regulated genes with circadian orthologs	1/48	0.2743181354387822	0.40953168446711813	0	0	3.1947130883301096	4.132255212667504	BTG1
Arf6 integrin-mediated signaling pathway	1/49	0.27915552222562046	0.4109247372621896	0	0	3.1279987373737375	3.991283301124502	CDH1
Ceramide signaling pathway	1/49	0.27915552222562046	0.4109247372621896	0	0	3.1279987373737375	3.991283301124502	MYC
FoxO family signaling	1/49	0.27915552222562046	0.4109247372621896	0	0	3.1279987373737375	3.991283301124502	CCNB1
Muscle contraction	1/49	0.27915552222562046	0.4109247372621896	0	0	3.1279987373737375	3.991283301124502	ITGB5
Insulin signaling pathway	3/277	0.2802043856162209	0.4110315203638641	0	0	1.6501684446939922	2.099403690622254	SOCS2;MKNK2;TRIB3
Type 2 diabetes mellitus	1/50	0.28396090387727224	0.4136593098004554	0	0	3.0640074211502784	3.857336278341556	SOCS2
Type II interferon signaling (interferon-gamma)	1/50	0.28396090387727224	0.4136593098004554	0	0	3.0640074211502784	3.857336278341556	ICAM1
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	3/280	0.2856250800987392	0.4146488231778248	0	0	1.6320466537073035	2.0450772472269225	SOCS2;HLA-DRA;ICAM1
Malaria	1/51	0.2887344905529836	0.4162918511055004	0	0	3.0025757575757575	3.729942921881929	ICAM1
Metabolism of vitamins and cofactors	1/51	0.2887344905529836	0.4162918511055004	0	0	3.0025757575757575	3.729942921881929	FLAD1
Pyruvate metabolism	1/52	0.29347649096814094	0.4188257718562282	0	0	2.9435531788472966	3.6086718081200515	ME1
Apoptotic execution  phase	1/52	0.29347649096814094	0.4188257718562282	0	0	2.9435531788472966	3.6086718081200515	CDH1
Vitamin B12 metabolism	1/52	0.29347649096814094	0.4188257718562282	0	0	2.9435531788472966	3.6086718081200515	ICAM1
RANKL signaling pathway	1/54	0.3028665615425825	0.4293159003684419	0	0	2.8321898227558604	3.382945842997971	ICAM1
Binding of chemokines to chemokine receptors	1/54	0.3028665615425825	0.4293159003684419	0	0	2.8321898227558604	3.382945842997971	CX3CL1
Interferon signaling	2/168	0.3075741718417054	0.434525927333416	0	0	1.811919433459027	2.1363236978890634	HLA-DRA;ICAM1
Thromboxane A2 receptor signaling	1/56	0.3121327589095778	0.43949127592285037	0	0	2.728925619834711	3.1773608860341893	ICAM1
Pathogenic Escherichia coli infection	1/57	0.3167199127807344	0.44298698764348565	0	0	2.6800595238095237	3.08136480695311	CDH1
PI3K cascade	1/57	0.3167199127807344	0.44298698764348565	0	0	2.6800595238095237	3.08136480695311	TRIB3
Transmembrane transport of small molecules	4/432	0.3238608046601636	0.4514748303375128	0	0	1.4083170325291603	1.5877950264331302	SLC22A15;ATP7B;SLC26A9;ABCG2
Caspase cascade in apoptosis	1/59	0.3258033347637175	0.45268384137136986	0	0	2.5873824451410656	2.9016494027801927	CFL2
Cytochrome P450 pathway	1/61	0.3347668988302152	0.46057798825987123	0	0	2.5008838383838383	2.7367692370960066	CYP4F11
FGF signaling pathway	1/61	0.3347668988302152	0.46057798825987123	0	0	2.5008838383838383	2.7367692370960066	CDH1
Ion channel transport	1/61	0.3347668988302152	0.46057798825987123	0	0	2.5008838383838383	2.7367692370960066	ATP7B
Signaling events mediated by focal adhesion kinase	1/62	0.33920422549151513	0.4621520353784073	0	0	2.4597615499254846	2.659378377076164	ITGB5
Circadian rhythm	1/62	0.33920422549151513	0.4621520353784073	0	0	2.4597615499254846	2.659378377076164	PER3
Colorectal cancer	1/62	0.33920422549151513	0.4621520353784073	0	0	2.4597615499254846	2.659378377076164	MYC
Ubiquitin-mediated degradation of phosphorylated Cdc25A	1/64	0.34799093952475324	0.4708261176751832	0	0	2.3814333814333812	2.5137906753442527	NQO1
Validated nuclear estrogen receptor alpha network	1/64	0.34799093952475324	0.4708261176751832	0	0	2.3814333814333812	2.5137906753442527	MYC
TGF-beta signaling pathway	2/185	0.3489257689184255	0.4708261176751832	0	0	1.6421807867183915	1.7290457062732674	CDH1;MYC
Interleukin-12-mediated signaling events	1/65	0.3523407117252142	0.47218417617927066	0	0	2.3441051136363638	2.445268815295598	HLA-DRA
Cell cycle	4/453	0.3555702344685846	0.47218417617927066	0	0	1.3409989468413874	1.386636471963087	CCNB1;CDH1;MYC;ORC3
Semaphorin interactions	1/66	0.3566616817696154	0.47218417617927066	0	0	2.307925407925408	2.3793963571890755	MYH14
Signaling by TGF-beta receptor complex	1/66	0.3566616817696154	0.47218417617927066	0	0	2.307925407925408	2.3793963571890755	MYC
Thyroid-stimulating hormone signaling pathway	1/66	0.3566616817696154	0.47218417617927066	0	0	2.307925407925408	2.3793963571890755	MYC
HIF-1 transcriptional activity in hypoxia	1/66	0.3566616817696154	0.47218417617927066	0	0	2.307925407925408	2.3793963571890755	ABCG2
SIDS susceptibility pathways	1/67	0.36095403903488765	0.4734007801672514	0	0	2.272842056932966	2.3160366121101177	NFYA
T cell receptor signaling in naive CD4+ T cells	1/67	0.36095403903488765	0.4734007801672514	0	0	2.272842056932966	2.3160366121101177	HLA-DRA
Telomerase regulation	1/67	0.36095403903488765	0.4734007801672514	0	0	2.272842056932966	2.3160366121101177	MYC
AMPK signaling	1/68	0.36521797151438384	0.47734026994329437	0	0	2.2388059701492535	2.255061764352553	CCNB1
Pathways in cancer	3/325	0.3673592576285686	0.47734026994329437	0	0	1.400740563784042	1.402722620255993	CDH1;MYC;RUNX1
Axon guidance	3/325	0.3673592576285686	0.47734026994329437	0	0	1.400740563784042	1.402722620255993	ABLIM3;CFL2;MYH14
PPAR signaling pathway	1/69	0.3694536659747048	0.47769097775038233	0	0	2.205770944741533	2.196352177093708	ME1
Amino acid metabolism	2/195	0.3728794278754592	0.47769097775038233	0	0	1.5563026539572045	1.535292819095664	NQO1;SUOX
AP-1 transcription factor network	1/70	0.37366130802261016	0.47769097775038233	0	0	2.173693456302152	2.1397957619349244	MYC
CDC42 signaling events	1/70	0.37366130802261016	0.47769097775038233	0	0	2.173693456302152	2.1397957619349244	CDH1
Rac1 cell motility signaling pathway	1/71	0.37784108216360407	0.47769097775038233	0	0	2.1425324675324675	2.085287405168396	CDH1
Bacterial invasion of epithelial cells	1/71	0.37784108216360407	0.47769097775038233	0	0	2.1425324675324675	2.085287405168396	CDH1
Interleukin-6 signaling pathway	1/71	0.37784108216360407	0.47769097775038233	0	0	2.1425324675324675	2.085287405168396	MYC
Melanoma	1/71	0.37784108216360407	0.47769097775038233	0	0	2.1425324675324675	2.085287405168396	CDH1
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	1/71	0.37784108216360407	0.47769097775038233	0	0	2.1425324675324675	2.085287405168396	STS
Sphingolipid metabolism	1/72	0.381993171491774	0.47909393091033076	0	0	2.1122492530943235	2.032728446948277	STS
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.381993171491774	0.47909393091033076	0	0	2.1122492530943235	2.032728446948277	MYC
Jak-STAT signaling pathway	2/199	0.3823647524605015	0.47909393091033076	0	0	1.5243926066571085	1.465520985806349	SOCS2;MYC
Signaling by NOTCH1	1/73	0.38611775801475434	0.4823607600124972	0	0	2.082807239057239	1.982026202461866	MYC
Adherens junction cell adhesion	1/74	0.39021502246163586	0.48317801310690794	0	0	2.0541718555417185	1.9330935272270466	CDH1
E2F transcription factor network	1/74	0.39021502246163586	0.48317801310690794	0	0	2.0541718555417185	1.9330935272270466	MYC
Wnt/calcium/cyclic GMP pathway	1/74	0.39021502246163586	0.48317801310690794	0	0	2.0541718555417185	1.9330935272270466	F3
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1/75	0.3942851446024616	0.48536270724455066	0	0	2.0263104013104014	1.8858484166961607	ITGB5
Glycolysis and gluconeogenesis	1/75	0.3942851446024616	0.48536270724455066	0	0	2.0263104013104014	1.8858484166961607	ALDH3A1
Phospholipid metabolism	2/205	0.3964782353963292	0.48663946676925535	0	0	1.4788854209754447	1.36816737911748	STS;LPIN1
Signaling by SCF-KIT	1/78	0.40633443538790825	0.49728720144857375	0	0	1.9470680834317198	1.7534880939718522	TRIB3
Antigen processing: cross presentation	1/79	0.41029776089919845	0.4979743087902225	0	0	1.922008547008547	1.7122638611776624	ITGB5
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	1/79	0.41029776089919845	0.4979743087902225	0	0	1.922008547008547	1.7122638611776624	CDH1
Antigen-activated B-cell receptor generation of second messengers	2/211	0.41044438277958956	0.4979743087902225	0	0	1.435991088060192	1.2787713823518079	MYC;HLA-DRA
APC/C-mediated degradation of cell cycle proteins	1/82	0.42203085688051944	0.5061965548338994	0	0	1.8505424616535728	1.5964201361502517	CCNB1
ATM-dependent DNA damage response	1/82	0.42203085688051944	0.5061965548338994	0	0	1.8505424616535728	1.5964201361502517	MYC
Platelet homeostasis	1/82	0.42203085688051944	0.5061965548338994	0	0	1.8505424616535728	1.5964201361502517	KCNMB2
Regular glucocorticoid receptor pathway	1/82	0.42203085688051944	0.5061965548338994	0	0	1.8505424616535728	1.5964201361502517	ICAM1
Response to elevated platelet cytosolic calcium	1/83	0.42589016735137797	0.5093743194742333	0	0	1.8278824833702882	1.5602325773118064	F13A1
Small cell lung cancer	1/84	0.4297239002029063	0.5110558248175807	0	0	1.8057685286600949	1.5251744349937915	MYC
ECM-receptor interaction	1/84	0.4297239002029063	0.5110558248175807	0	0	1.8057685286600949	1.5251744349937915	ITGB5
TGF-beta regulation of skeletal system development	1/85	0.4335322237039414	0.5141325807869277	0	0	1.7841810966810967	1.4911992053106211	MYC
Progesterone-mediated oocyte maturation	1/86	0.43731530489265164	0.5157135668341915	0	0	1.763101604278075	1.4582627871632894	CCNB1
Glycerophospholipid biosynthesis	1/86	0.43731530489265164	0.5157135668341915	0	0	1.763101604278075	1.4582627871632894	LPIN1
Mitotic G2-G2/M phases	1/87	0.44107330992725546	0.5186923560876384	0	0	1.7425123326286116	1.426323331393078	CCNB1
DNA replication pre-Initiation	1/88	0.4448064037918686	0.520176377767713	0	0	1.7223963775687914	1.3953411034566685	ORC3
Hematopoietic cell lineage	1/88	0.4448064037918686	0.520176377767713	0	0	1.7223963775687914	1.3953411034566685	HLA-DRA
Salivary secretion	1/89	0.44851475034153765	0.5230601382099372	0	0	1.702737603305785	1.3652783546249518	LYZ
Signaling by ERBB4	1/93	0.4631039036987331	0.5385821642463168	0	0	1.6283761528326746	1.2535302089614808	TRIB3
ERBB signaling pathway	1/94	0.46669093472805845	0.5397716580233863	0	0	1.6107852720755946	1.2275602076257284	MYC
Fc gamma receptor-mediated phagocytosis	1/94	0.46669093472805845	0.5397716580233863	0	0	1.6107852720755946	1.2275602076257284	CFL2
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	1/95	0.4702541795886745	0.5409207912754972	0	0	1.5935686653771761	1.2023187508095157	BRF2
Transport of inorganic cations/anions and amino acids/oligopeptides	1/95	0.4702541795886745	0.5409207912754972	0	0	1.5935686653771761	1.2023187508095157	SLC26A9
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	1/96	0.4737937947277701	0.543507323107333	0	0	1.5767145135566187	1.1777790701778137	SLC22A15
Apoptosis	2/242	0.4799066225798582	0.5485581592032894	0	0	1.2485368956743002	0.9166305047414324	CDH1;MYC
Downstream signaling events Of B cell receptor (BCR)	1/98	0.4808027571164223	0.5485581592032894	0	0	1.5440487347703842	1.1307040494954523	TRIB3
Potassium channels	1/99	0.48427241233894464	0.5490099510208156	0	0	1.5282158317872603	1.1081210595353999	KCNMB2
Senescence and autophagy	1/99	0.48427241233894464	0.5490099510208156	0	0	1.5282158317872603	1.1081210595353999	IGFBP5
Pyrimidine metabolism	1/100	0.487719053875974	0.5490099510208156	0	0	1.512702785430058	1.0861444222602046	UPRT
Dilated cardiomyopathy	1/100	0.487719053875974	0.5490099510208156	0	0	1.512702785430058	1.0861444222602046	ITGB5
Integrin-mediated cell adhesion	1/100	0.487719053875974	0.5490099510208156	0	0	1.512702785430058	1.0861444222602046	ITGB5
Signaling by ERBB2	1/102	0.49454390098005757	0.5552079528336114	0	0	1.4825982598259826	1.043926127965857	TRIB3
SLC-mediated transmembrane transport	2/251	0.49913476910289206	0.5588716430646744	0	0	1.2028572304485117	0.8358403994398972	SLC22A15;SLC26A9
Interleukin-4 signaling pathway	1/104	0.5012784986329878	0.5597831509933364	0	0	1.4536628420123565	1.0038900326222	HLA-DRA
Signaling by insulin receptor	1/109	0.5177278864982588	0.5766228577136693	0	0	1.3860129068462401	0.9124199063278433	TRIB3
Glycosaminoglycan metabolism	1/110	0.5209525626293606	0.5786834534748306	0	0	1.3732276897414513	0.8954766845377898	HYAL1
Signaling by EGFR in cancer	1/111	0.5241558381282374	0.5807094943473367	0	0	1.3606749311294766	0.8789500662229016	TRIB3
Cytokine-cytokine receptor interaction	2/265	0.5281356386855595	0.5835829498336498	0	0	1.1380141061736277	0.726510637109031	TNFRSF14;CX3CL1
Oocyte meiosis	1/113	0.5304987502989232	0.5846596174760385	0	0	1.3362418831168832	0.8470940748055895	CCNB1
CXCR4 signaling pathway	1/116	0.5398561082287948	0.5918734936570902	0	0	1.3011857707509882	0.80211940503907	HLA-DRA
Vascular smooth muscle contraction	1/116	0.5398561082287948	0.5918734936570902	0	0	1.3011857707509882	0.80211940503907	KCNMB2
Leukocyte transendothelial migration	1/117	0.5429339082939053	0.5937017542642445	0	0	1.2899033437826541	0.7878312756800375	ICAM1
p53 activity regulation	1/118	0.5459912752813225	0.5954982562006135	0	0	1.2788137788137788	0.7738770774013868	CCNB1
Signaling by NOTCH	1/119	0.5490283439088413	0.59726339221091	0	0	1.2679121725731894	0.7602467452023173	MYC
Notch signaling pathway	1/121	0.5550421200772828	0.6022493107024125	0	0	1.2466540404040405	0.7339192909618074	MYC
Signaling by PDGF	1/122	0.5580190924801853	0.6039229766944936	0	0	1.2362885048835461	0.7212038599871197	TRIB3
Rho GTPase cycle	1/123	0.5609762962749735	0.6055667198250354	0	0	1.2260928961748634	0.7087756457866075	HMHA1
Signaling by FGFR in disease	1/128	0.575470316173939	0.6196240488727066	0	0	1.1775232641374374	0.6506612409172355	TRIB3
PDGFB signaling pathway	1/129	0.57831161455909	0.6210948717586146	0	0	1.168264678030303	0.6397913072192183	MYC
Tight junction	1/133	0.589489305184859	0.6314885432132967	0	0	1.1326331496786042	0.5985951487103497	MYH14
NGF signaling via TRKA from the plasma membrane	1/136	0.5976791339413245	0.6386368410895878	0	0	1.1072951739618406	0.5699261928276235	TRIB3
Natural killer cell-mediated cytotoxicity	1/137	0.6003728767370318	0.63989109140833	0	0	1.0990975935828877	0.5607643794366315	ICAM1
Hemostasis pathway	3/468	0.6051021279807902	0.6423238106288937	0	0	0.96287841191067	0.48370970080599024	KCNMB2;F13A1;F3
T cell receptor signaling pathway	1/139	0.6057067762937549	0.6423238106288937	0	0	1.0830588493631972	0.54300160222462	HLA-DRA
MAPK signaling pathway	2/314	0.6204744035286659	0.6563309645366039	0	0	0.9568898023096496	0.4566956825567651	MYC;MKNK2
Innate immune system	2/319	0.6290802097252355	0.6637663365772536	0	0	0.9415560960339057	0.4364079653995432	TXNIP;LGMN
Signaling by the B cell receptor (BCR)	1/151	0.6362583152507988	0.6696618768014657	0	0	0.9958080808080808	0.45025526309231084	TRIB3
Myometrial relaxation and contraction pathways	1/155	0.6459105867421241	0.6781255785995867	0	0	0.9697461629279811	0.4238704188224676	IGFBP5
Toll receptor cascades	1/159	0.6553085986335644	0.6862808955839069	0	0	0.9450038358266206	0.39940493693206663	LGMN
Protein processing in the endoplasmic reticulum	1/166	0.6711632068547831	0.701140719816039	0	0	0.9045913682277319	0.3606994237409947	WFS1
Signal transduction	6/1020	0.6778611433647307	0.7063850033578011	0	0	0.8783953780925313	0.34153137991466215	ITGB5;CDH1;MYC;HMHA1;CX3CL1;ICAM1
Transcription	1/181	0.7027413500820614	0.7305039713198712	0	0	0.828577441077441	0.2922942627328301	BRF2
Chemokine signaling pathway	1/189	0.7183327108105824	0.7448720966779684	0	0	0.7929964539007093	0.2623410152356916	CX3CL1
Peptide G-protein coupled receptors	1/192	0.7239678364609493	0.7488709070026035	0	0	0.7804220212597176	0.2520828000164031	CX3CL1
Post-translational protein modification	1/196	0.7313076405447086	0.7546091094836332	0	0	0.7642579642579642	0.2391524114224122	STS
Messenger RNA processing	1/203	0.7436891671484295	0.765508898213909	0	0	0.7375112511251125	0.21840076850288667	CSTF2T
Platelet activation, signaling and aggregation	1/205	0.7471215549869086	0.7671662796328989	0	0	0.7302064765300059	0.2128751830609774	F13A1
DNA replication	1/207	0.7505083186600311	0.7687688616931219	0	0	0.7230435422182995	0.20751678199113907	ORC3
Developmental biology	2/420	0.7719868917897904	0.7879608962639686	0	0	0.7103619562438365	0.18383294296735067	ABLIM3;MYH14
Signaling by NGF	1/221	0.7729877675938694	0.7879608962639686	0	0	0.6765495867768595	0.17420614348124674	TRIB3
Wnt signaling pathway	1/231	0.7878022047749145	0.8011225319087899	0	0	0.6468050065876153	0.15426831714778003	MYC
Focal adhesion	1/233	0.7906478593793742	0.8020789127679917	0	0	0.6411637931034483	0.1506110384579236	ITGB5
Carbohydrate metabolism	1/235	0.793455635377586	0.8029923617643359	0	0	0.6356190106190106	0.14705532098994073	HYAL1
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	1/255	0.819556987053165	0.8274184449625479	0	0	0.5849737532808399	0.11640471360872022	ITGB5
Neuronal system	1/283	0.8506870836099264	0.8567924933009067	0	0	0.5261390500752203	0.08508243107977233	KCNMB2
GPCR ligand binding	1/410	0.9369631293041358	0.941435507009645	0	0	0.36041342520560127	0.023467003680939083	CX3CL1
Protein metabolism	1/442	0.9493185418246676	0.9515788240671073	0	0	0.3337112622826909	0.01735661514341814	STS
Signaling by GPCR	1/977	0.9987461653971939	0.9987461653971939	0	0	0.14663282414307005	1.839686660740163E-4	CX3CL1
